首页> 外文期刊>European radiology >Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?
【24h】

Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?

机译:加64排行造影剂增强扫描的Gadoxetic acid增强的3.0T MRI是否能提供更好的诊断性能并改变大肠肝转移的术前评估的治疗策略?

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives To compare diagnostic performance in the detection of colorectal liver metastases between 64-detector-row contrast-enhanced CT (CE-CT) alone and the combination of CE-CT and gadoxetic acid-enhanced MRI (EOB-MRI) at 3.0T, and to assess whether EOB-MRI in addition to CE-CT results in a change to initially planned operative strategy. Methods A total of 39 patients (27 men, mean age 65 years) with 85 histopathologically confirmed liver metastases were included. At EOB-MRI, unenhanced (Tl- and T2-weighted), dynamic, and hepatocyte-phase images were obtained. At CE-CT, four-phase dynamic contrast-enhanced images were obtained.
机译:目的比较3.0T时单独使用64排行对比增强CT(CE-CT)以及结合使用CE-CT和牛磺酸增强MRI(EOB-MRI)的大肠肝转移的诊断性能,以及评估除CE-CT之外的EOB-MRI是否会导致改变最初计划的手术策略。方法纳入39例患者(27例男性,平均年龄65岁),其中85例经病理组织学证实为肝转移。在EOB-MRI上,获得未增强(T1和T2加权),动态和肝细胞期的图像。在CE-CT上,获得了四相动态对比度增强图像。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号